Alexander Asam and Board - Free people check

(1 - 13 from 16

)

APR Applied Pharma Research s.a. ("APR") today announced that HBM...

www.apr.ch

The fund’s advisor, Alexander Asam, will become a member of the Board of Directors of APR. “We have followed the progress of APR for quite some time and are pleased to invest in APR. This investment underlines our strategy to invest in attractive, growing and internationally oriented firms.

Curetis AG - akampionwww.akampion.com › news › tag › curetis-ag › page

www.akampion.com

Dr. Alexander Asam of HBM will join Curetis' supervisory board. In addition, the company's existing institutional investors aeris Capital, LSP Life Sciences ...

Alexander Asam - MarketVisual Knowledge Map

www.marketvisual.com

Executive. PARTNER at Deutsche Venture Capital Gmbh. MANAGING DIRECTOR at Kaneas Capital Gmbh. Past Affiliations. Board Member. DIRECTOR at ...

Just a moment...

www.zoominfo.com

View Alexander Asam's business profile as Board Member at Autonomic Technologies Inc and see work history, affiliations and more.

Arcutis Announces the Completion of $94.5 million Series C ...

finance.yahoo.com

· In connection with the financing, Dr. Alexander Asam, Investment Advisor of HBM Partners, has joined Arcutis' Board of Directors.Dr. Asam brings more than 20 years of …

Alexander Asam | Technology Vision Group LLC | Email Advisory Board...

www.joesdata.com

Email, phone number & executive profile for Alexander Asam, Advisory Board Member of Technology Vision Group LLC at Santa Cruz, CA

Arcutis Announces the Completion of $94.5 million Series C ...ca.sports.yahoo.com › news › arcutis-announces-completi...

ca.sports.yahoo.com

View photos. In connection with the financing, Dr. Alexander Asam, Investment Advisor of HBM Partners, has joined Arcutis' Board of Directors.

Curetis raises EUR million in Series B round led by ...

www.gesundheitsindustrie-bw.de

Curetis raises EUR million in Series B round led by new investor HBM Partners. On the 22nd April the Curetis AG in Holzgerlingen announced the closing of a Series B financing round totaling EUR million. The financing was led by HBM Partners. Dr. Alexander Asam of HBM will join Curetis’ supervisory board.

Swixx BioPharma - Board and Management

www.swixxbiopharma.com

Alexander Asam Board Observer More than 20 years experience in the life sciences and private equity business. Formerly various positions at Hoechst, Aventis and Deutsche Bank. Matthias Fehr Board Member For 17 years investment advisor at HBM Partners. Board …